The Role of Theranostics in Prostate Cancer.

Dipeptides / therapeutic use Heterocyclic Compounds, 1-Ring / therapeutic use Humans Male Precision Medicine Prostate-Specific Antigen Prostatic Neoplasms, Castration-Resistant / diagnostic imaging

Journal

Seminars in radiation oncology
ISSN: 1532-9461
Titre abrégé: Semin Radiat Oncol
Pays: United States
ID NLM: 9202882

Informations de publication

Date de publication:
01 2021
Historique:
entrez: 28 11 2020
pubmed: 29 11 2020
medline: 22 3 2022
Statut: ppublish

Résumé

Theranostics in men with metastatic castration-resistant prostate cancer (mCRPC) has been developed to target bone and the tumor itself. Currently, bone-directed targeted alpha therapy with radium-223 (

Identifiants

DOI: 10.1016/j.semradonc.2020.07.004 PMID: 33246638 PMC: PMC8391014
pubmed: 33246638
pii: S1053-4296(20)30049-7
doi: 10.1016/j.semradonc.2020.07.004
pmc: PMC8391014
mid: NIHMS1730983
pii:
doi:

Substances chimiques

Dipeptides 0
Heterocyclic Compounds, 1-Ring 0
Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-82

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Références

Br J Radiol. 2017 Aug;90(1077):20160748
pubmed: 28654303
J Urol. 2002 Sep;168(3):1005-7
pubmed: 12187209
Nat Rev Urol. 2015 Jun;12(6):340-56
pubmed: 26119830
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7195s-7200s
pubmed: 16203821
Australas Phys Eng Sci Med. 2017 Jun;40(2):369-376
pubmed: 28342027
Lancet Oncol. 2014 Jun;15(7):738-46
pubmed: 24836273
Nat Commun. 2018 Apr 24;9(1):1629
pubmed: 29691406
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1102-1110
pubmed: 30637501
Lancet Oncol. 2016 Sep;17(9):1306-16
pubmed: 27473888
N Engl J Med. 2013 Jan 10;368(2):138-48
pubmed: 23228172
Transl Androl Urol. 2018 Jun;7(3):472-482
pubmed: 30050805
Oncology (Williston Park). 2008 Aug;22(9):1064-70; discussion 1075, 1080-1, 1084
pubmed: 18777956
Urol Oncol. 1996 Nov-Dec;2(6):191-7
pubmed: 21224168
N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2106-19
pubmed: 25070685
BJU Int. 2005 Dec;96(9):1241-6
pubmed: 16287438
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6250s-6257s
pubmed: 17062709
Ann Oncol. 2016 May;27(5):868-74
pubmed: 26912557
Clin Genitourin Cancer. 2018 Apr;16(2):149-154
pubmed: 29196208
Oncologist. 2018 Feb;23(2):193-202
pubmed: 29183960
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1473-1479
pubmed: 28337529
Clin Cancer Res. 2009 Aug 1;15(15):4792-8
pubmed: 19638458
Lancet Oncol. 2019 Mar;20(3):408-419
pubmed: 30738780
J Nucl Med. 2016 Jul;57(7):1006-13
pubmed: 26795286
Nat Clin Pract Oncol. 2007 Mar;4(3):172-80
pubmed: 17327857
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):950-959
pubmed: 28280855
Oncotarget. 2016 Mar 15;7(11):12477-88
pubmed: 26871285
Urol Oncol. 2008 May-Jun;26(3):276-80
pubmed: 18452819
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):21-33
pubmed: 26266887
Bioorg Med Chem Lett. 1999 May 17;9(10):1415-8
pubmed: 10360747
J Nucl Med. 2016 Oct;57(Suppl 3):19S-24S
pubmed: 27694165
Cancer Res. 1997 Sep 1;57(17):3629-34
pubmed: 9288760
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):2040-2041
pubmed: 31814067
Nat Rev Immunol. 2015 Dec;15(12):760-70
pubmed: 26603901
BJU Int. 2019 Nov;124 Suppl 1:5-13
pubmed: 31638341
Respir Med. 2014 Jun;108(6):910-7
pubmed: 24650574
Nat Rev Urol. 2018 Jul;15(7):403-421
pubmed: 29769644
J Bone Oncol. 2016 Apr 13;5(3):124-127
pubmed: 27761372
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1099-1100
pubmed: 28255795
N Engl J Med. 2014 Jul 31;371(5):424-33
pubmed: 24881730
Clin Cancer Res. 2013 Sep 15;19(18):5182-91
pubmed: 23714732
J Clin Oncol. 2005 Jul 20;23(21):4591-601
pubmed: 15837970
N Engl J Med. 2011 May 26;364(21):1995-2005
pubmed: 21612468
Cancer Res. 1994 Apr 1;54(7):1807-11
pubmed: 7511053
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
Oncotarget. 2017 Feb 25;8(33):55567-55574
pubmed: 28903443
Prostate Cancer Prostatic Dis. 2013 Mar;16(1):23-7
pubmed: 23146970
Eur J Cancer. 2019 Jun;114:107-116
pubmed: 31082669
EJNMMI Res. 2015 Dec;5(1):114
pubmed: 26099227
J Med Chem. 2001 Feb 1;44(3):298-301
pubmed: 11462970
Lancet. 2010 Oct 2;376(9747):1147-54
pubmed: 20888992
J Nucl Med. 2016 Oct;57(Suppl 3):79S-89S
pubmed: 27694178
Eur Urol. 2019 Mar;75(3):e51-e52
pubmed: 30454914
Eur Urol. 2018 Mar;73(3):427-435
pubmed: 28705540
Mol Cell Endocrinol. 2009 Oct 30;310(1-2):71-81
pubmed: 19616059
Curr Radiopharm. 2018;11(3):156-172
pubmed: 29658444
J Clin Oncol. 2009 May 20;27(15):2429-35
pubmed: 19364971
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Crit Rev Oncol Hematol. 2018 Mar;123:7-20
pubmed: 29482781
J Nucl Med. 2003 May;44(5):792-805
pubmed: 12732682
Clin Cancer Res. 2017 Aug 1;23(15):4335-4346
pubmed: 28364014
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):721-728
pubmed: 31758224
J Bone Miner Res. 2005 Mar;20(3):464-70
pubmed: 15746991
J Nucl Med. 2017 Jan;58(1):85-90
pubmed: 27765862
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268
pubmed: 28497198
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):243-246
pubmed: 29134280
N Engl J Med. 2015 Aug 20;373(8):737-46
pubmed: 26244877
J Clin Oncol. 1993 Apr;11(4):607-15
pubmed: 7683043
Nat Clin Pract Oncol. 2007 Feb;4(2):86-100
pubmed: 17259930
Breast Cancer Res Treat. 2001 Mar;66(2):101-9
pubmed: 11437096
Lancet. 2016 Mar 19;387(10024):1163-77
pubmed: 26719232
J Nucl Med. 2016 Dec;57(12):1941-1944
pubmed: 27390158
Eur Urol. 2016 Sep;70(3):416-26
pubmed: 26391636
Cancer. 2019 Aug 1;125(15):2561-2569
pubmed: 31012963
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Clin Pharmacol Ther. 2015 Dec;98(6):582-9
pubmed: 26331358
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
N Engl J Med. 2012 Sep 27;367(13):1187-97
pubmed: 22894553
Clin Genitourin Cancer. 2017 Feb;15(1):42-52.e8
pubmed: 27613490
J Clin Oncol. 2009 May 20;27(15):2436-42
pubmed: 19364960
J Nucl Med. 2013 Aug;54(8):1369-76
pubmed: 23733925
Semin Nucl Med. 2014 May;44(3):172-8
pubmed: 24832581
J Med Chem. 2009 Jan 22;52(2):347-57
pubmed: 19111054
J Natl Cancer Inst. 2015 Dec 18;108(5):
pubmed: 26683407
JAMA Oncol. 2019 Jun 1;5(6):856-863
pubmed: 30920593
Cancer Res. 2002 Jun 1;62(11):3120-5
pubmed: 12036923
N Engl J Med. 2017 Jul 27;377(4):352-360
pubmed: 28578607
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1557-63
pubmed: 23333070
Ann Oncol. 2015 Sep;26 Suppl 5:v69-77
pubmed: 26205393
Theranostics. 2019 Apr 6;9(8):2129-2142
pubmed: 31149033

Auteurs

Elisabeth O'Dwyer (E)

Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: elisabethodwyer@gmail.com.

Lisa Bodei (L)

Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY.

Michael J Morris (MJ)

Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Oligopeptides › Dipeptides › The Role of Theranostics in Prostate Cancer.
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › The Role of Theranostics in Prostate Cancer.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Role of Theranostics in Prostate Cancer.
questionsmedicales.fr › Professions de santé › Médecine › Médecine clinique › Médecine de précision › The Role of Theranostics in Prostate Cancer.
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Antigène spécifique de la prostate › The Role of Theranostics in Prostate Cancer.
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Tumeurs prostatiques résistantes à la castration › The Role of Theranostics in Prostate Cancer.